Experimental DNA-Launched Live-Attenuated Vaccines Against Yellow Fever
Background DNA-launched vaccine is “manufactured” in vaccinated individuals and does not require traditional vaccine manufacturing facility and technology. Goals. Using yellow fever 17D vaccine, we have provided proof-of-concept evidence that these vaccine can be launched from DNA and induce specifi...
Main Authors: | P. Pushko, А. А. Ishmukhametov, P. P. Bredenbeek, I. S. Lukashevich |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Numikom LLC
2019-03-01
|
Series: | Эпидемиология и вакцинопрофилактика |
Subjects: | |
Online Access: | https://www.epidemvac.ru/jour/article/view/657 |
Similar Items
-
The thermal stability of yellow fever vaccines
by: Ricardo Ishak, et al.
Published: (1990-09-01) -
A Phase 2a Randomized, Double-Blind, Dose-Optimizing Study to Evaluate the Immunogenicity and Safety of a Bivalent DNA Vaccine for Hemorrhagic Fever with Renal Syndrome Delivered by Intramuscular Electroporation
by: Jay Hooper, et al.
Published: (2020-07-01) -
Attenuation of Live-Attenuated Yellow Fever 17D Vaccine Virus Is Localized to a High-Fidelity Replication Complex
by: Emily H. Davis, et al.
Published: (2019-10-01) -
Vaccination against yellow fever in rheumatic diseases
by: B. S. Belov, et al.
Published: (2019-10-01) -
Viscerotropic disease and acute uveitis following yellow fever vaccination: a case report
by: Lev Volkov, et al.
Published: (2020-02-01)